What Researchers Did
Researchers looked back at records of 126 people with sudden hearing loss whose first treatment with steroid medicine had not worked, and compared those who got steroid injections into the middle ear, those who got hyperbaric oxygen therapy, and those who got no further treatment.
What They Found
In this retrospective, nonrandomized cohort study of 126 people with sudden sensorineural hearing loss, both middle-ear steroid injections (ITS) and hyperbaric oxygen (HBO) therapy were associated with better hearing recovery than no second-line treatment, with average gains of 13.6 dB for ITS and 7.4 dB for HBO compared with the control group. Of the 126 patients, 43 received ITS, 35 received HBO, and 48 received no second-line therapy. The abstract reports that hearing improvement was statistically significant at all frequencies for both treatments. Having tinnitus (ringing in the ears) before treatment was linked to 4.67 dB less improvement on average. ITS was also linked to a larger reduction in tinnitus than the other two options.
What This Means for Canadian Patients
For people with sudden hearing loss who did not respond to oral steroids, this study found that HBO was associated with better hearing outcomes than observation alone. ITS was linked to larger hearing gains than HBO in this group. Because patients were not randomly assigned to treatments, the results show an association and do not prove that either treatment caused the improvement. Anyone considering these options should talk with their physician.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was retrospective and nonrandomized, so the groups may have differed in ways that affected the results, and the abstract does not report that the difference between ITS and HBO was tested directly.